Elysia Holt Ragusa
CIK 1421287 · View on SEC EDGAR ↗
Insider
First SEC filing: Jan. 3, 2008 · Latest: Jan. 3, 2008
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 36 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
36 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 28, 2023 | TCBIO | S | 10,077 | $17.77 | $179,068 | 0 Direct | -100.00% | Disposed | 16.3% (price as of 2026-08-21) |
| June 2, 2022 | TCBIO | P | 2,000 | $55.91 | $111,820 | 14,164 Direct | +16.44% | Acquired | -63.0% (price as of 2026-08-21) |
| March 1, 2021 | TCBIO | P | 10,077 | $24.75 | $249,406 | 10,077 Direct | — | Acquired | -16.5% (price as of 2026-08-21) |
| April 21, 2017 | TCBIO | S | 2,249 | $74.05 | $166,538 | 5,812 Direct | -27.90% | Disposed | -72.1% (price as of 2026-08-21) |
| Dec. 8, 2015 | FOSL | S | 2,718 | $37.07 | $100,756 | 4,532 Direct | -37.49% | Disposed | -84.5% (price as of 2026-08-21) |
| Dec. 17, 2014 | FOSL | S | 987 | $106.16 | $104,780 | 5,586 Direct | -15.02% | Disposed | -94.6% (price as of 2026-08-21) |
| March 28, 2012 | FOSL | S | 2,000 | $132.88 | $265,760 | 2,578 Direct | -43.69% | Disposed | -95.7% (price as of 2026-08-21) |
| June 15, 2011 | FOSL | S | 7,803 | $106.22 | $828,835 | 3,578 Direct | -68.56% | Disposed | -94.6% (price as of 2026-08-21) |
| June 15, 2011 | FOSL | S | 1,197 | $107.00 | $128,079 | 11,381 Direct | -9.52% | Disposed | -94.6% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 23, 2025 | TCBIO | 2024 Restricted Stock Units | Common Stock (1,330) | $0.00 | — | 1,330 | Disposed |
| April 22, 2025 | TCBIO | 2025 Restricted Stock Units | Common Stock (1,670) | $0.00 | — | 1,670 | Acquired |
| April 23, 2024 | TCBIO | 2024 Restricted Stock Units | Common Stock (1,330) | $0.00 | — | 1,330 | Acquired |
| April 18, 2024 | TCBIO | Restricted Stock Units | Common Stock (1,631) | $0.00 | — | 1,631 | Disposed |
| April 19, 2023 | TCBIO | Restricted Stock Units | Common Stock (1,377) | $0.00 | — | 1,377 | Disposed |
| April 18, 2023 | TCBIO | Restricted Stock Units | Common Stock (1,631) | $0.00 | — | 1,631 | Acquired |
| April 21, 2017 | TCBIO | Stock Appreciation Rights | Common Stock (3,000) | $18.52 | May 18, 2020 | 3,000 | Disposed |
| March 28, 2012 | FOSL | Stock Options (Right to Buy) | Common Stock (1,000) | $16.42 | Jan. 1, 2019 | 1,000 | Disposed |
| June 15, 2011 | FOSL | Stock Options (Right to Buy) | Common Stock (4,000) | $42.76 | Jan. 1, 2018 | 4,000 | Disposed |
| June 15, 2011 | FOSL | Stock Options (Right to Buy) | Common Stock (5,000) | $43.92 | Dec. 20, 2017 | 5,000 | Disposed |
| Jan. 1, 2009 | FOSL | Stock Options (Right to Buy) | Common Stock (6,000) | $16.42 | Jan. 1, 2019 | 6,000 | Acquired |
| Jan. 1, 2008 | FOSL | Stock Options (Right to buy) | Common Stock (4,000) | $42.76 | Jan. 1, 2018 | 4,000 | Acquired |
| Dec. 20, 2007 | FOSL | Stock Options (Right to buy) | Common Stock (5,000) | $43.92 | Dec. 20, 2017 | 5,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).